Esther Culebras - Concepedia

Author

Esther Culebras

Also Known As

E CULEBRAS, E Culebras, E. CULEBRAS, E. Culebras, E. Culebras-López, Ester Culebras, Esther Culebras, Esther Culebras López, Esther Culebras,, Esther Culebras-López

114

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Hospital Clínico San Carlos Universidad Complutense de Madrid Hospital Universitario Ramón y Cajal Instituto de Investigación Sanitaria del Hospital Clínico San Carlos

About

Esther Culebras is an author at Hospital Clínico San Carlos specializing in medicine, clinical microbiology, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	26	1.1K
2	Health Sciences	14	17	718
3	Public Health	3	3	40
4	Education	1	1	11
5	Natural Sciences	1	1	40

Esther Culebras

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Induction of the SOS response by new 4-quinolones Ian Phillips, Esther Culebras, Felipe Moreno, Journal of Antimicrobial Chemotherapy BacteriologyPharmaceutical ChemistryGalactose OperonsDrug ResistanceSos Response	1987	190
Inhibition of Nuclear Factor κB Activation by a Virus-encoded IκB-like Protein Yolanda Revilla, Mario Callejo, Javier M. Rodrı́guez, Journal of Biological Chemistry Viral PathogenesisImmunologyInnate ImmunityTumor Necrosis FactorNf-kb Signaling Pathway	1998	136
Panuveitis and Optic Neuritis as a Possible Initial Presentation of the Novel Coronavirus Disease 2019 (COVID-19) Blanca Benito-Pascual, José A. Gegúndez, David Díaz‐Valle, Ocular Immunology and Inflammation	2020	126
Identification of Acinetobacter species: Is Bruker biotyper MALDI-TOF mass spectrometry a good alternative to molecular techniques? Arturo Álvarez-Buylla, Esther Culebras, Juan J. Picazo Infection Genetics and Evolution Molecular Diagnostic TechniquesAcinetobacter SpeciesGood AlternativeMedicineMass Spectrometry	2012	77
Erythromycin and Clindamycin Resistance and Telithromycin Susceptibility in <i>Streptococcus agalactiae</i> Carmen Betriú, Esther Culebras, Marı́a Gómez, Antimicrobial Agents and Chemotherapy Antimicrobial Resistance GeneAntimicrobial SusceptibilityHealth SciencesAntibioticsDrug Resistance	2003	77
In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci Iciar Rodríguez-Avial, Esther Culebras, Carmen Betriú, Journal of Antimicrobial Chemotherapy	2011	69
Can Plazomicin Alone or in Combination Be a Therapeutic Option against Carbapenem-Resistant Acinetobacter baumannii? Cristina García‐Salguero, Iciar Rodríguez-Avial, Juan J. Picazo, Antimicrobial Agents and Chemotherapy PharmacotherapyAntimicrobial ChemotherapyDrug ResistanceNosocomial PathogensDisk Diffusion	2015	62
In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains Iciar Rodríguez-Avial, Irene Peña, Juan J. Picazo, International Journal of Antimicrobial Agents AntibioticsMedicineAntibacterial AgentAntimicrobial ChemotherapyMicrobiology	2015	58
Comparative In Vitro Activities of Linezolid, Quinupristin-Dalfopristin, Moxifloxacin, and Trovafloxacin against Erythromycin-Susceptible and -Resistant Streptococci Carmen Betriú, M.J. López Redondo, M. Luisa Palau, Antimicrobial Agents and Chemotherapy Macrolide Resistance PhenotypesAntimicrobial SusceptibilityHealth SciencesAntibioticsMedicine	2000	58
Postantibiotic effect of imipenem on Gram-positive and Gram-negative micro-organisms Fernando Baquero, Esther Culebras, C. Patrón, Journal of Antimicrobial Chemotherapy	1986	58

Page 1